Mode
Text Size
Log in / Sign up

SLE patients have significantly higher odds of HPV infection and associated cancersLupus patients face higher risks of HPV and related cancers

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize that SLE patients have significantly higher odds of HPV infection and associated anogenital cancers.

This meta-analysis evaluates the risk of human papillomavirus (HPV) infection and associated malignancies in patients with systemic lupus erythematosus (SLE). The analysis indicates that SLE patients have significantly increased odds of HPV infection (OR 4.12; 95% CI 2.03, 8.32). Furthermore, the study identifies substantially elevated risks for HPV-associated malignancies (SIR 1.90; 95% CI 1.51, 2.38).

Specific cancer types showed distinct risk profiles: the risk of cervical cancer more than doubled (SIR 2.25; 95% CI 1.75, 2.89), and the risk for vulvar and vaginal cancers was notably higher (SIR 5.60; 95% CI 3.71, 8.43). These findings suggest that the current clinical focus on cervical cancer may not capture the full scope of anogenital risks in the SLE population.

The authors note a need for additional prospective evidence to better characterize these risks. Clinical application is currently limited by the lack of prospective data, but the findings suggest a need for increased awareness of extra-cervical anogenital cancer risks in patients with SLE.

How this fits prior evidence

This meta-analysis addresses a gap in the clinical management of SLE patients by identifying risks beyond the cervix-focused screening paradigm. While previous coverage noted that school-based education improves cervical cancer literacy, this finding highlights that SLE patients specifically face significantly higher odds of HPV infection (OR 4.12) and higher risks of vulvar and vaginal cancers (SIR 5.60).

Living with systemic lupus erythematosus (SLE) already brings many health challenges. New data shows that these patients also face a much higher risk of contracting human papillomavirus (HPV). This virus is a common cause of several types of cancer. Specifically, the study found that the odds of an HPV infection are more than four times higher for people with lupus.

Beyond just the infection, the risk of cancers linked to HPV is substantially elevated for those with lupus. This includes a more than doubled risk of cervical cancer. Even more concerning, the risk for vulvar and vaginal cancers is significantly higher than in the general population.

While these findings highlight a serious link between lupus and these specific cancers, the evidence is still developing. Researchers note that more forward-looking studies are needed to fully understand these risks. For now, these results suggest that doctors should look beyond just cervical screening when monitoring patients with lupus.

What this means for you:
People with lupus have significantly higher risks of HPV infection and related cancers of the cervix, vulva, and vagina.

Common questions

How much higher is the risk of HPV for people with lupus?

The study found that people with systemic lupus erythematosus have significantly increased odds of an HPV infection. Specifically, the odds are more than four times higher compared to the general population. This means the link between lupus and the virus is quite strong.

What specific cancers are linked to lupus and HPV?

Patients with lupus show substantially elevated risks for cancers linked to HPV. This includes a more than doubled risk of cervical cancer. Additionally, there is a much higher risk for cancers of the vulva and vagina.

Is this finding certain for everyone with lupus?

While the data shows a clear link, researchers note that more prospective evidence is needed to fully understand the risks. Because the evidence is still being gathered, you should talk to your doctor about what these findings mean for your specific care.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedNov 2026
View Original Abstract ↓
OBJECTIVE: The current cervix-focused screening paradigm in systemic lupus erythematosus (SLE) may underestimate extra-cervical anogenital cancer risk. This meta-analysis aimed to quantify the risk of human papillomavirus (HPV) infection and HPV-associated cancers in SLE patients. METHODS: A comprehensive search was conducted in PubMed (2010), Embase (2010), and Cochrane Library (2010) to August 8, 2025. Odds Ratios (ORs) and Standardized Incidence Ratios (SIRs) with 95% Confidence Intervals (CIs) were calculated. The study protocol was registered with PROSPERO (CRD420251122192). RESULTS: SLE was associated with significantly increased odds of HPV infection (OR = 4.12, 95% CI 2.03, 8.32). We further assessed the risk of HPV-associated malignancies in SLE patients. SLE patients exhibited substantially elevated risks across multiple HPV-associated cancers (SIR = 1.90, 95% CI 1.51, 2.38). The risk of cervical cancer was more than doubled (SIR = 2.25, 95% CI 1.75, 2.89). Notably, even higher risks were observed for extra-cervical anogenital cancers, namely vulvar/vaginal cancers (SIR = 5.60, 95% CI 3.71, 8.43). CONCLUSIONS: SLE is associated with elevated risks of HPV infection and a broad spectrum of HPV-associated cancers. Subgroup analyses suggested that cyclophosphamide use, multiple sexual partners, and Asian populations may constitute higher-risk subgroups. These findings highlight the need for additional prospective evidence to better characterize HPV-associated cancer risks in SLE patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.